Continuing Medical Education Questions: May 2015
- Which one of the following tests is the preferred method of diagnosing primary sclerosing cholangitis (PSC)?
Which one of the following treatments is the best for PSC patients with decompensated cirrhosis?
- A. Liver biopsy
- B. Endoscopic retrograde cholangiopancreatography (ERCP)
- C. Magnetic resonance cholangiography (MRCP)
- D. Serum antimitochondrial antibody (AMA) level
Which one of the following statements is true regarding PSC patients and hepatobiliary malignancies?
- A. Ursodeoxycholic acid (28 mg/kg per day)
- B. Liver transplantation
- C. Vancomycin
- D. Biliary reconstruction by biliary-enteric drainage
© The American College of Gastroenterology 2015. All Rights Reserved.
- A. Cholecystectomy should only be performed in PSC patients with symptomatic gallbladder polyps.
- B. The 10-year cumulative risk for cholangiocarcinoma is 1–3%.
- C. CA 19-9 levels have limited predictive value as a screening tool for cholangiocarcinoma.
- D. Conventional endoscopic techniques with brush cytology for detection of cholangiocarcinoma have a sensitivity of >90%.